拟南芥花期基因FT转化切花菊‘神马’

采用RT-PCR方法从拟南芥叶片中克隆FT基因,经过测序分析、酶切之后,连接到植物表达载体Super1300+,构建植物重组载体FT-Super 1300+,运用农杆菌介导法将FT基因导入切花菊'神马'中,鉴定其在转化植株体内的整合和表达.扩增得到的基因片段经测序分析与GenBbank上的FT基因同源性为100%;构建的植物表达载体经过酶切分析证实外源基因已经正确插入;转化后得到了29株抗性植株,PCR和PCR-Southern杂交结果显示,8株抗性植株为阳性,说明外源基因整合到转化植株的基因组中.RT-PCR鉴定结果表明外源基因在转化植株叶片中表达.其中转FT基因的一个株系在组培条件下分化出花芽,表明转基因植株花芽分化不受光周期影响,花期可以提前.     

拟南芥花期基因FT 转化切花菊‘神马’

 采用RT-PCR 方法从拟南芥叶片中克隆FT 基因,经过测序分析、酶切之后,连接到植物表达载体Super1300⁺,构建植物重组载体FT- Super1300⁺,运用农杆菌介导法将FT 基因导入切花菊‘神马’中,鉴定其在转化植株体内的整合和表达。扩增得到的基因片段经测序分析与GenBbank 上的FT 基因同源性为100%;构建的植物表达载体经过酶切分析证实外源基因已经正确插入;转化后得到了29 株抗性植株,PCR 和PCR-Southern 杂交结果显示,8 株抗性植株为阳性,说明外源基因整合到转化植株的基因组中。RT-PCR 鉴定结果表明外源基因在转化植株叶片中表达。其中转FT 基因的一个株系在组培条件下分化出花芽,表明转基因植株花芽分化不受光周期影响,可以提前花期。     

紫花苜蓿MsSAG113基因的克隆及对拟南芥的转化

以紫花苜蓿为试材,采用RT-PCR技术克隆出一个与拟南芥SAG113同源的基因,利用无缝连接酶将其与3302Y连接构建过量表达的植物表达载体,通过花序浸泡法转化拟南芥获得具有草铵膦抗性的植株,以期为研究MsSAG113的功能提供参考依据。结果表明:MsSAG113基因编码区长849bp,编码283个氨基酸,PCR和RT-PCR检测显示成功获得了转MsSAG113基因拟南芥植株,初步证明在转基因拟南芥中外源SAG113基因能够转录表达。     

柑桔钙离子结合蛋白基因克隆及植物表达载体构建

以伏令夏橙叶片中分离的总RNA为模板,经RT-PCR扩增到一条约600bp、含钙离子结合蛋白基因(CsCaBP)的片段,将此片段克隆到pMD-19T中,经测序分析该片段与甜橙基因组中的对应序列完全吻合。设计2对带有限制性内切酶位点的特异性引物,以cDNA为模板扩增到2个CsCaBP片段,并连接到TA克隆载体pMD-19T上;经双酶切消化后,分别以正反2个方向插入到植物表达载体pFGC5941的查耳酮合成酶(CHSA)内含子两侧,构建成功CsCaBP的RNA干扰载体,但未获得转基因植株。将CsCaBP的正向片段定向克隆到具有CaMV35S启动子的pF-GC5941表达质粒上,构建成功CsCaBP过量表达载体。将构建好的表达载体导入根癌农杆菌LBA4404菌株,转化酸橙下胚轴,经PCR检测,获得9株过量表达转基因植株,荧光定量PCR验证发现目的基因在转基因植株中有不同程度的表达。     

PRK基因原核表达质粒的构建

以拟南芥cDNA为模板,扩增出PRK基因,构建重组质粒pET-28a（＋）-PRK转化大肠杆菌DH5α。经PCR鉴定和酶切鉴定筛选出阳性克隆,将阳性克隆的质粒转化到大肠杆菌表达载体BL21中,构建PRK基因原核表达载体。测序结果表明pET-28a（＋）-PRK载体构建成功。     

结球甘蓝春化相关基因VIN3反义植物表达载体构建及转化

以pBI121植物表达载体和BoVIN3-1基因片段为基础,构建结球甘蓝春化相关基因VIN3反义植物表达载体。将BoVIN3-1基因片段反向插入355启动子与GUS基因之间的限制性酶切位点XbaⅠ和SmaⅠ中,构建含反义BoVIN3-1基因的工程质粒pBI35S-BoVIN3-1。通过花蕾微量注射法转化结球甘蓝,获得9株转化植株。PCR检测结果表明,其中5株为阳性植株,阳性株率55.6%。经春化处理的转反义基因植株与对照相比,春化一定程度被推迟。半定量RT-PCR检测结果表明,转化植株在进行低温处理后仍有该基因少量表达,并随春化处理时间的延长转录水平升高,在第50天时表达量达到最高。     

八氢番茄红素合成酶(PSY2)基因果实特异表达载体的构建

八氢番茄红素合成酶是番茄红素合成的关键酶,通过PCR法获取PSY2基因和E8启动子序列,将目的基因和E8启动子序列构建到植物表达载体pBI101.2中,构建了果实特异表达启动子的八氢番茄红素合成酶基因植物表达载体。并采用PCR、限制性内切酶酶切和序列测定分析法,对重组质粒进行鉴定。结果表明,番茄果实特异性表达PSY2蛋白的重组质粒构建成功;通过农杆菌直接转化技术将其成功转入转化农杆菌LBA4404、EHA105,为下一步PSY2蛋白在番茄果实中特异表达奠定了基础。     

平邑甜茶MhVPE基因ihpRNA干扰载体的构建及转拟南芥验证

 根据平邑甜茶液泡加工酶（vacuolar processing enzyme）基因MhVPE（GenBank登录号为FJ891065）cDNA序列,设计两对含有酶切位点的特异性引物F1/F2和R1/R2,以pMD-MhVPE质粒为模板,分别克隆了用于构建干扰载体的正反义片段pMD-F和pMD-R。将该正反义片段分别插入表达载体pART27的相应位置,构建成了含有内含子发夹结构的ihpRNA表达载体pART-RNAi-MhVPE。通过农杆菌介导,用花序浸泡法转化拟南芥进行验证,经过抗性筛选和PCR检测,得到17株转基因阳性植株;半定量RT-PCR结果显示所获得的转基因拟南芥植株中AtVPE同源基因的表达量明显降低,表明该干扰载体能够有效抑制VPE基因的表达,MhVPE基因的ihpRNA干扰载体构建成功,为进一步鉴定该基因的功能奠定了基础。     

LEAFY基因植物表达载体的构建

本研究采用植物中间表达载体pBll21构建拟南芥花分生组织特性基因-LEAFY基因的植物表达载体。LEAYY基因带有植物组成型启动子-CαMV35S。该表达载体的构建为利用LEAFY基因进行木本果树遗传转化创造了条件。     

山茶花CjAPL1基因正义表达载体的构建及对拟南芥的转化分析

 为研究山茶花CjAPL1基因对于重瓣花形成的作用,构建了pCAMBIA1300-CjAPL1正义植物表达载体,酶切结果显示,CjAPL1基因正向插入pCAMBIA1300的启动子和终止子之间,表明CjAPL1植物表达载体构建成功。将pCAMBIA1300-CjAPL1采用农杆菌介导的花序浸染法转化拟南芥,获得转基因阳性植株65株。随机挑选表型变异明显的3株进行PCR扩增都得到了目的条带,Southern杂交鉴定进一步确认为转基因阳性植株。同时荧光定量检测到在转基因植株中CjAPL1基因表现出较对照显著提高6 ~ 25倍的表达量。转基因阳性植株表型变异明显,花柱和雄蕊数相比野生型各增加1枚和1 ~ 4枚,萼片边缘发育成白色的瓣化状,表明在拟南芥中过量表达CjAPL1基因可以引起花器官形态的变异和数量的变化,因此该基因在花器官形成和重瓣花发育中具有显著的调控功能。     

Conditionally replicating adenovirus activated by CXCR4 promoter in lung cancer

AIM: To construct a conditionally replicating adenovirus vector activated by CXCR4 promoter and to evaluate its ability of lysing the lung cancer cells specifically. METHODS: Human CXCR4-E1A gene amplified by PCR was cloned into the shuttle plasmid pDC316-GFP to construct the recombinant shuttle plasmid pDC316-CXCR4-GFP. The recombinat shuttle plasmid and adenovirus genomic plasmid pBHG-lox-E1, 3Cre were transfected into 293 cells to construct the recombinant adenovirus CRAd-CXCR4-GFP. PCR was used to detect the target gene fragments, and the viral titer was determined. A549 cells with the highest mRNA expression of CXCR4 were screened out from 5 kinds of lung cancer cell lines by real-time PCR. CXCR4 promoter activity and adenovirus replication numbers were detected in A549 cells after transfection of CRAd-CXCR4-GFP and Ad-NULL. CRAd-CXCR4-GFP and Ad-NULL were transfected into A549 cells and 16HBE cells, the apoptotic rates were detected by flow cytometry and the viability was analyzed by CCK-8 assay. RESULTS: The recombinant plasmid pDC316-CXCR4-GFP was constructed successfully. Green fluorescence was observed in 293 cells under fluorescent microscope after co-transfection of pDC316-CXCR4-GFP and pBHG-lox-E1, 3Cre at 11 d. Green fluorescence was observed in 293 cells after infection of amplified 3rd generational adenovirus. PCR showed that the purpose gene was successfully integrated in recombinant adenovirus genome. The virus in the supernatant reached a titer of 1×10¹³ PFU/L. The mRNA expression of E1A and E4 in the A549 cells after transfection of CRAd-CXCR4-GFP was markedly increased compared with Ad-NULL group. Compared with Ad-NULL group and empty control group, the apoptotic rate and the viability of A549 cells in CRAd-CXCR4-GFP group had no significant difference in the first 4 d, the apoptotic rate increased significantly at 5 d, and the cell viability declined significantly at 5 d, but the apoptotic rate and the viability of 16HBE cells in each group had no significant difference within 5 days. CONCLUSION: The conditionally replicating adenovirus vector CRAd-CXCR4-GFP has been successfully constructed, which has the ability of lysing lung cancer cells specifically.     

Construction of mouse pdx-1 gene eukaryotic expression vector and its expression in embryonic stem cells

AIM: To clone mouse pdx-1 gene and construct its eukaryotic expression vector for expression of pdx-1 in mouse embryonic stem cells.METHODS: Mouse pdx-1 cDNA fragment was amplified with polymerase chain reaction (PCR) from mouse pancreatic cDNA. The purified fragment was recombinated with a eukaryotic expression vector carrying enhanced green fluorescent protein, pEGFP-N1. The pdx-1 cDNA fragment was inserted into the multi-clone sites of the vector to construct a new plasmid, pEGFP/pdx-1. E.colli strain DH5α was transfected with the new recombinant plasmid to expand it. Plasmid DNA extracted from the expanded DH5α was identifed by cutting with Hind Ⅲ, BamHⅠ nuclease and by DNA sequencing. Identified plasmid DNA was transfected into mouse embryonic stem cell line MESPU13 by carrying with liposome. RESULTS: A 876 bp cDNA fragment was amplified from mouse pancreatic cDNA by PCR and it was inserted into the vector pEGFP-N1 correctly. The fragment was defined to be pdx-1 gene by nuclease digestion and DNA sequencing. Mouse embryonic stem cell line MESPU13 was transfected with the new recombinant plasmid DNA. The green fluorescent protein report gene and pdx-1 gene expressed in transfected mouse embryonic stem cells within 24 h. CONCLUSION: Mouse pdx-1 gene is cloned and its recombinant eukaryotic expression vector carrying green fluorescent protein is constructed successfully. It provides a useful tool for further research on the function of pdx-1.     

Construction of eukaryotic expression vector and expression of outer membrane lipoprotein LipL41 gene of Leptospiria lai

AIM:To construct a eukaryotic expression vector expressing outer membrane lipoprotein LipL41 of Leptospira lai and express it in mammalian cell. METHODS:LipL41 gene was amplified by PCR from genome of Leptospira lai 017 strain, and was subcloned into vector pGEX-4T-1. After sequencing, LipL41 gene digested by restriction endonuclease and cloned into vector pcDNA3. After confirming the correctness of the eukaryotic recombinant vector by restrication enzyme digestion, it was transfected into COS7 cells by liposome. Its expression was analyzed by RT-PCR. RESULTS:A fragment of 1 011 bp was amplified, and sequence analysis showed it had a 98% homology with Leptospira kirschneri. The analysis of restriction enzyme indicated that the eukaryotic recombinant vector was correctly constructed. A specific amplified fragment was showed in the cells transfected with recombinant plasmid by RT-PCR, but the cell transfected with blank plasmid did not show this band. CONCLUSIONS:The LipL41 gene of Leptospira lai was successfully inserted into eukaryotic expression plasmid and the recombinant plasmid expressed the LipL41 mRNA.     

Construction of prokaryotic expression vector of human angiogenesis inhibitor arresten and its expression in E.coli

AIM:To construct prokaryotic expression vector of human angiogenesis inhibitor arresten gene and express recombinant arresten in Escherichia coli.METHODS:Human arresten gene was amplified from recombinant plasmid pGEM-Arr with polymerase chain reaction (PCR), and then cloned into prokaryotic expression vector pRSET by means of recombinant gene technology. The recombinant plasmid pRSET-Arr was transformed into E.coli BL21(DE3), and recombinant arresten was expressed in the bacteria under induction of IPTG. The expressed products were detected by SDS-PAGE analysis.RESULTS:Restriction analysis indicated that the arresten gene was successfully inserted into the expression vector, and DNA sequencing verified that the reading frame of the recombinant vector was correct. Recombinant arresten was successfully expressed in Escherichia coli; its molecular weight was about 26 kD and its amount was approximately 30% of total bacterial proteins.CONCLUSION:The successful construction of prokaryotic expression vector containing human arresten gene and the effective expression of recombinant arresten in Escherichia coli laid the foundation for further study on its biological functions.     

香石竹ACC氧化酶基因的克隆及其正义反义表达载体的构建

利用在Genebank上已报道的香石竹ACC氧化酶(ACO)基因的CDNA序列设计特异引物,以香石竹品种'MASTER'的eDNA为模板进行PCR扩增,克隆香石竹ACC氧化酶(AC0)基因.测序结果显示,克隆基因的序列与报道序列完全一致.将克隆的ACC氧化酶(AC0)基因分别连接到植物表达载体PBI121启动子CaMV 35S的上游及下游,构建香石竹ACC氧化酶(Aco)基因的正义表达栽体PBI121-ACO及反义表达载体PBI121-anti ACO.经PCR鉴定,基因已成功构建到表达裁体上.为香石竹抗衰老基因工程育种奠定了基础.     

Prokaryotic expression and identification of a small peptide of osteopontin

AIM: To express osteopontin 13 peptide (OPN 13) in E.coli, and to test the biological activity of the purified products. METHODS: cDNA fragments containing RGD sequences were cloned into prokaryotic expression vector pET-32c(+) including His coding sequence to construct pET-32c-OPN 13 plasmid. E.coli DH5α transformed by pET-32c-OPN 13 plasmid was induced by IPTG at different concentrations for different times to identify the optimal induction condition. Expressed His-OPN 13 fusion protein was purified via Ni-NTA His Bind Resin metal chelation chromatography, and detected by VSMCs adhesion and migration analysis. RESULTS: His-OPN 13 fusion protein was expressed in soluble manner. The fusion proteins were purified via Ni-NTA His Bind Resin affinity chromatography. His-OPN 13 fusion protein specifically inhibited adhesion and migration of VSMCs stimulated by osteopontin in dose-dependent manner. CONCLUSION: The OPN 13 peptide is successfully expressed in E.coli DH5α. The purified His-OPN 13 fusion protein could inhibit the adhesion and migration of VSMCs stimulated by osteopontin.     

Construction and identification of eukaryotic dicistronic vector expressing TCA-12-2/TCB-7.1

AIM: To construct the recombinant dicistronic eukaryotic expression vector pDC315-TCA-12-2-TCB-7.1, which containing T cell antigen receptor (TCR) genes TCA-12-2 and TCB-7.1, and to transfer this recombinant vector into 293 cells to investigate the expression of TCA-12-2 and TCB-7.1. METHODS: The TCA-12-2 was obtained by RT-PCR from the T cells and the TCB-7.1 was amplified by PCR from plamid pcDNA3.1-TCB-7.1 that we constructed before. TCA-12-2 and TCB-7.1 was cloned into vector pIRES2-AcGFP1 firstly, then subcloned into vector pDC315. The recombinant plasmid pDC315-TCA-12-2-TCB-7.1 was verified by restriction enzyme digestion and sequencing, the positive recombinant plasmid was transferred into 293 cells using Lipofectamine 2000. The expressions of gene TCA-12-2 and TCB-7.1 were identified by RT-PCR and flow cytometry. RESULTS: Both TCA-12-2 and TCB-7.1 genes were constructed into eukaryotic expression vector pDC315 and the expressions of genes in 293 cells were detected successfully with RT-PCR and flow cytometry. CONCLUSION: The dicistronic expression vector pDC315-TCA-12-2-TCB-7.1 is successfully constructed and expressed.     

Construction of an eukaryotic expression vector encoding human granzyme B and it's expression in Hep2 cells

AIM: To construct pVAX1-GrB. METHODS: Lymphocytes from human laryngeal carcinoma tissue were separated from tumor tissue. The fragment of granzyme B (GrB) was amplified by RT-PCR and was recombined to the downstream of T7 promoter in the vector pVAX1. The construction was transfected into Hep2 cells with lipofectamine 2000. The expression of protein was identified by indirect immunofluorescent antibody assay. RESULTS: It has been proved that the sequence of the RT-PCR product was totally consistent with the data of GenBank by DNA sequencing analysis. The GrB cDNA fragment was cloned into the vector of pVAX1 in the right direction and the open reading fragment of GrB was maintained. The target protein was detected in the transfected Hep2 cells. CONCLUSION: The pVAX1-GrB plasmid was successfully constructed and expressed.